We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.75B
AUM Growth
+$430M
Cap. Flow
-$1.1B
Cap. Flow %
-19.08%
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
378
Reduced
937
Closed
183

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$6.27M
2
TJX icon
TJX Companies
TJX
+$5.89M
3
GIS icon
General Mills
GIS
+$5.87M
4
HPQ icon
HP
HPQ
+$5.84M
5
F icon
Ford
F
+$5.38M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.7M
2
AMZN icon
Amazon
AMZN
+$14.9M
3
IRM icon
Iron Mountain
IRM
+$14.6M
4
MSFT icon
Microsoft
MSFT
+$12.9M
5
GDS icon
GDS Holdings
GDS
+$9.75M

Sector Composition

Rank Sector Weight
1 Real Estate 17.47%
2 Technology 14.6%
3 Consumer Discretionary 9.29%
4 Healthcare 7.36%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLXN
1351
DELISTED
Flexion Therapeutics, Inc.
FLXN
$26K ﹤0.01%
2,861
-922
-24% -$10.6K
STTK icon
1352
Shattuck Labs
STTK
$651M
$25K ﹤0.01%
+870
New +$36.6K
PRTA icon
1353
Prothena Corp
PRTA
$448M
$24K ﹤0.01%
+952
New +$17.9K
SPRO icon
1354
Spero Therapeutics
SPRO
$69.5M
$24K ﹤0.01%
+1,608
New +$28.3K
QGEN icon
1355
Qiagen
QGEN
$8.72B
$23K ﹤0.01%
446
ITOS
1356
DELISTED
iTeos Therapeutics
ITOS
$22K ﹤0.01%
+640
New +$23.1K
ISEE
1357
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$22K ﹤0.01%
3,528
-736
-17% -$4.47K
KSA icon
1358
iShares MSCI Saudi Arabia ETF
KSA
$622M
$21K ﹤0.01%
573
+241
+73% +$7.88K
NGNE icon
1359
Neurogene
NGNE
$663M
$20K ﹤0.01%
81
+14
+21% +$3.58K
PMVP icon
1360
PMV Pharmaceuticals
PMVP
$58.7M
$20K ﹤0.01%
+614
New +$24.2K
CERE
1361
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$20K ﹤0.01%
+1,444
New +$21.1K
CUE icon
1362
Cue Biopharma
CUE
$127M
$19K ﹤0.01%
51
-10
-16% -$4.12K
ANNX icon
1363
Annexon
ANNX
$814M
$16K ﹤0.01%
+558
New +$15.3K
KRRO icon
1364
Korro Bio
KRRO
$151M
$14K ﹤0.01%
29
+15
+107% +$29.1K
RCEL icon
1365
Avita Medical
RCEL
$142M
$14K ﹤0.01%
697
+96
+16% +$2.23K
BCEL
1366
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$14K ﹤0.01%
897
-184
-17% -$2.99K
AMTI
1367
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$12K ﹤0.01%
277
-414
-60% -$20.1K
KALV
1368
DELISTED
KalVista Pharmaceuticals
KALV
$11K ﹤0.01%
+430
New +$11.3K
BPYU
1369
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$8K ﹤0.01%
468
-16
-3% -$284
TARO
1370
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$7K ﹤0.01%
93
-5
-5% -$380
SCL icon
1371
Stepan Co
SCL
$1.32B
$6K ﹤0.01%
46
FROG icon
1372
JFrog
FROG
$9.26B
$4K ﹤0.01%
+87
New +$5.02K
NNOX icon
1373
Nano X Imaging
NNOX
$61.1M
$4K ﹤0.01%
+98
New +$5.28K
ARD
1374
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$4K ﹤0.01%
153
-5
-3% -$108
ACA icon
1375
Arcosa
ACA
$7.13B
-14,509
Closed -$797K

Similar funds

Pacer Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Pacer Advisors held 1,587 positions worth $5.75B, up 8.1% from $5.32B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pacer Advisors withdrew a net $1.1B in Q1 2021, closing 183 positions and reducing 937 holdings. Its most notable exit was Rithm Capital, an estimated $4.39M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pacer Advisors opened a new position in Aerojet Rocketdyne Holdings worth $3.39M.

  • Pacer Advisors's largest Q1 2021 buy was Aerojet Rocketdyne Holdings: 72,150 shares worth $3.39M.
  • Pacer Advisors added most to Newmont in Q1 2021, an estimated $6.27M increase.
  • Pacer Advisors's biggest Q1 2021 reduction was Apple, cutting an estimated $16.7M.
  • Pacer Advisors fully exited Rithm Capital in Q1 2021, selling an estimated $4.39M.
  • Pacer Advisors's ten largest holdings make up 27% of its $5.75B portfolio in Q1 2021.
  • Pacer Advisors opened 76 new positions and closed 183 in Q1 2021.
  • Pacer Advisors's portfolio value rose 8.1% quarter-over-quarter to $5.75B.

Based on Pacer Advisors's 13F filing for Q1 2021, filed 5 Apr 2021.